PTSD Treatment for Incarcerated Men and Women
3 other identifiers
interventional
58
1 country
1
Brief Summary
There is a particular need for more effective treatments for post-traumatic stress disorder (PTSD) within the incarcerated population. The prevalence of trauma history and PTSD are markedly higher in jail and prison populations than in the general population, with estimates of current PTSD prevalence among prison inmates exceeding 20%, as opposed to 3-6% in the general population. Cognitive Processing Therapy (CPT) is a potentially promising PTSD treatment for the prison setting. The primary objectives of this project include:
- 1.Establish the feasibility of group CPT delivery in male and female prisons with PTSD by examining participant retention in the 12-week course;
- 2.Obtain preliminary efficacy estimates for reducing PTSD symptom severity, as well as secondary symptoms associated with trauma, including depression, hopelessness, self-blame, and negative self-related thoughts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2019
CompletedFirst Submitted
Initial submission to the registry
March 25, 2019
CompletedFirst Posted
Study publicly available on registry
March 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2019
CompletedAugust 23, 2023
August 1, 2023
8 months
March 25, 2019
August 22, 2023
Conditions
Outcome Measures
Primary Outcomes (8)
PTSD-Checklist-5 (PCL-5)
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD. Participants rate on a 0 ("not at all") - 4 ("Extremely") scale how bothered they have been by PTSD symptoms in the last month. Total scores range from 0-80.
4 months
Eligibility
Percentage of inmates who meet the full set of inclusion criteria.
3 months
Participation
Percentage of eligible inmates agreeing to participate in randomization into one of the two groups.
4 months
Retention
Percentage of inmates attending all 12 sessions.
12 weeks
Compliance
Compliance will be measured in three ways: Percentage of retained inmates performing intervention activities during session (e.g., attending to and contributing to the discussion); the percentage of inmates completing the homework assignment each week; and the percentage of inmates fully completing the pre-, mid-, and post-intervention assessment batteries. All three measures of compliance will be reported individually. An overall metric of compliance will be calculated by averaging the three individual measures.
4 months
Adherence
Adherence will by measured by the presence or absence of five session elements (scores 0-5) by the clinical supervisors, as in previous CPT studies.
12 weeks
Competence
Ratings of the quality of session elements (scores 1-7; 1="not satisfactory", 4="satisfactory", 7="excellent") by the clinical supervisors, as in previous CPT studies
12 weeks
Safety-Suicidal ideation item on the Beck Depression Inventory-II (BDI-II)
The BDI-II is a 21-item self-report questionnaire assessing symptoms of depression in the last 2-weeks. Each item is on a 0-3 scale, with higher scores indicative of greater symptom severity. Scores range from 0-63.
4 months
Secondary Outcomes (3)
Posttraumatic Cognition Inventory (PCTI)
4 months
Beck Hopelessness Scale (BHS)
4 months
Beck Depression Inventory (BDI-II)
4 months
Study Arms (2)
Cognitive Processing Therapy
EXPERIMENTAL12 sessions of group-based Cognitive Processing Therapy administered 1x/week for 90 minutes each session.
Control
NO INTERVENTIONNo treatment/treatment as usual. Participants will complete questionnaires at three time points with no intervention.
Interventions
Group-based psychotherapy.
Eligibility Criteria
You may qualify if:
- DSM 5 criteria for current PTSD diagnosis
- IQ greater than 70
- Reading level of 5th grade or higher
- No history of psychosis or dementia
- Stable medication use (same medication for at least one month) if using medication
- No scheduled transfer or release for at least 12 weeks (the duration of the intervention).
You may not qualify if:
- Other vulnerable populations within the prison setting will not be eligible for participation, such as:
- pregnant women
- individuals who have English as a second language
- those with visual or hearing impairments
- individuals appearing to lack the capacity to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fox Lake Correctional Institute
Fox Lake, Wisconsin, 53933, United States
Related Publications (9)
Goff A, Rose E, Rose S, Purves D. Does PTSD occur in sentenced prison populations? A systematic literature review. Crim Behav Ment Health. 2007;17(3):152-62. doi: 10.1002/cbm.653.
PMID: 17595672BACKGROUNDEgeressy A, Butler T, Hunter M. 'Traumatisers or traumatised': Trauma experiences and personality characteristics of Australian prisoners. Int J Prison Health. 2009;5(4):212-22. doi: 10.1080/17449200903343209.
PMID: 25757522BACKGROUNDKessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617.
PMID: 15939839BACKGROUNDKessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995 Dec;52(12):1048-60. doi: 10.1001/archpsyc.1995.03950240066012.
PMID: 7492257BACKGROUNDKilpatrick DG, Resnick HS, Milanak ME, Miller MW, Keyes KM, Friedman MJ. National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria. J Trauma Stress. 2013 Oct;26(5):537-47. doi: 10.1002/jts.21848.
PMID: 24151000BACKGROUNDElbogen EB, Johnson SC, Wagner HR, Sullivan C, Taft CT, Beckham JC. Violent behaviour and post-traumatic stress disorder in US Iraq and Afghanistan veterans. Br J Psychiatry. 2014;204(5):368-75. doi: 10.1192/bjp.bp.113.134627. Epub 2014 Feb 27.
PMID: 24578444BACKGROUNDCampbell CA, Albert I, Jarrett M, Byrne M, Roberts A, Phillip P, Huddy V, Valmaggia L. Treating Multiple Incident Post-Traumatic Stress Disorder (PTSD) in an Inner City London Prison: The Need for an Evidence Base. Behav Cogn Psychother. 2016 Jan;44(1):112-7. doi: 10.1017/S135246581500003X. Epub 2015 Feb 20.
PMID: 25697197BACKGROUNDHeckman CJ, Cropsey KL, Olds-Davis T. Posttraumatic stress disorder treatment in correctional settings: A brief review of the empirical literature and suggestions for future research. Psychotherapy (Chic). 2007 Mar;44(1):46-53. doi: 10.1037/0033-3204.44.1.46.
PMID: 22122167BACKGROUNDResick, P.A., C.M. Monson, and K.M. Chard, Cognitive Processing Therapy for PTSD: A Comprehensive Manual. 2016: Guilford Press.
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Koenigs, PhD
UW-Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2019
First Posted
March 27, 2019
Study Start
March 5, 2019
Primary Completion
October 17, 2019
Study Completion
October 17, 2019
Last Updated
August 23, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
Informed consent gives permission to share de-identified participant data (all primary and secondary outcome measures) with other UW-Madison researchers. Other data sharing is not currently approved.